The technology accurately detects the presence of these gene fusions in acute promyelocytic leukemia ... Radon, Even at Levels Below EPA Guideline for Mitigation, Is Linked to Childhood Leukemia ...

The CAR-T cell therapy Aucatzyl was approved for relapsed or refractory B-cell precursor acute lymphoblastic leukemia based ...

a unique portfolio of clinical trials to test precision medicine treatments for adults with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). The National Institutes of Health (NIH ...

BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will share new data across ...

Here, a link between the activity of a lineage-specific transcription factor PU.1 and epigenetic modulators mediating the response to glucocorticoids is described in acute lymphoblastic leukemia.

Chronic lymphocytic leukemia (CLL) is a type of cancer that affects lymphocytes. It can be challenging to detect CLL early because it does not cause symptoms in its early stages. CLL can follow ...

S‚Ö2 ©j?|DÊ^ ;GÈIë ª31Æ ýñëÏ¿ÿ Œ; Lf‹Õfw8]n ×ç÷äOíéëWãŒ_â[K–Di/{/qâ¤Û)u/“ H€0 B1¶9íŸúi•_ =cË½Ò &À k(o«õ ë7jI¾Y ...

These mature B cells divide rapidly and eventually crowd out normal cells, leading to symptoms like fevers ... like chronic lymphocytic leukemia (CLL), transforms or evolves into B-PLL.

The FDA has granted accelerated approval to asciminib as a first-line treatment for adults newly diagnosed with Philadelphia chromosome-positive chronic myeloid leukemia, a rare type of blood cancer.

For children with acute lymphoblastic leukemia (ALL), measurable residual disease (MRD) after the end of first consolidation (EOC) can be used to predict the need for subsequent MRD measurements ...

Acute lymphoblastic leukemia (ALL) affects both children and adults, but children have better chances to be cured, with long-term survival rates over 85% compared to 50-75% in adults. Scientists ...